Abstract:Based on our hypothesis that epitope vaccine may be a new strategy to induce high levels of neutralization antibodies against HIV–1, we prepared multiple–epitope vaccines using three neutralizing epitopes (GPGRAFY, RILAVERYLKD and ELDKWA) of HIV–1 gp160, and characterized their immunogenicity. Peptide 1 [C–G–(ELDKWA–GPGRAFY)2–K] and peptide 2 (CG–GPGRAFY–ELDKWA–G–RILAVERYLKD) were synthesized and conjugated with carrier protein bovine serum albumin (BSA). After vaccination antibody responses to these immunogens were induced and evaluated by ELISA. The C–G–(ELDKWA–GPGRAFY)2–K–BSA (BSA: carrier protein) multiple–epitope vaccine induced a strong antibody response to the C–G–(ELDKWA–GPGRAFY)2–K peptide (antibody titer: 1:25,600) and C–(ELDKWAG)4 peptide (antibody titer: 1:12,800), but a weak antibody response to the C–(GPCGRAFY)4 peptide. The CG–GPGRAFY–ELDKWA–G–RILAVERYLKD–K–BSA (BSA: carrier protein) multiple–epitope vaccine also induced strong antibody response to the CG–GPGRAFY–ELDKWA–G–RILAVERYLKD–K peptide (antibody titer: 1:25,600) and C–(ELLDKWAG)4 peptide (antibody titer: 1:6,400), a very strong response to C–(RIVALVERYLKD–G)2–K peptide (dilution: 1:102,400), and a very weak response to the C–(GPGRAFY)4 peptide (dilution: 1:400) in mice. Both antisera induced by both multiple–epitope vaccines interacted with the recombinant soluble gp41 (rgp41), but did not bind two control peptides. In comparison with both epitope vaccines, the rgp160 subunit vaccine could induce weak epitope–specific antibody response to these three epitopes on the three epitope peptides and V3, N–domain and C–domain peptides (dilution: 1:400–1:1,600). These results indicate that both multiple–epitope vaccines could induce high levels of antibodies to both neutralizing epitopes RILAVERYLKD and ELDKWA, while the GPGRAFY epitope on both vaccines appeared to have weak immunogenicity. Both multiple–epitope vaccines showed significant potency on inducing high levels of epitope–specific neutralization antibodies in comparison with rgp160 subunit vaccine.

Epitope competition weakens specific T cell response to subdominant epitopes

The Average IFN-γ Secreting Capacity of Specific CD8+ T Cells is Compromised While Increasing Copies of a Single T Cell Epitope Encoded by DNA Vaccine

V3ctl Epitope Density in A Single Recombinant Molecule Antigen Differentially Affects the Number and Activity of Primary and Memory Cd8(+) T Cells

The Immunologic Dominance of an Epitope Within a Rationally Designed Poly-Epitope Vaccine is Influenced by Multiple Factors.

Modulation of B cell receptor activation by antibody competition

Competition for self-peptide-MHC complexes and cytokines between naive and memory CD8+ T cells expressing the same or different T cell receptors.

Glutamic Acid Decarboxylase-Derived Epitopes with Specific Domains Expand CD4(+)CD25(+) Regulatory T Cells.

Immunogenicity of Multi-Epitope Vaccines Composed of Epitopes from Streptococcus Dysgalactiae GapC

Co-inoculation of DNA and protein vaccines induces antigen-specific T cell suppression.

Immunodominance Analysis Through Interactions of CD8+ T Cells and DCs in Lymph Nodes

Epitope-Vaccines: A New Strategy to Induce High Levels of Neutralizing Antibodies Against Hiv-1

Immunodominance in major histocompatibility complex class I-restricted T lymphocyte responses.

Immunogenicity of Neutralizing Epitopes on Multiple–Epitope Vaccines Against HIV–1

Efficient induction of CD25 - iTreg by co-immunization requires strongly antigenic epitopes for T cells

Identification of a dominant murine T-cell epitope in recombinant protein P29 from <italic>Echinococcus granulosus</italic>

T cell epitope mapping reveals immunodominance of evolutionarily conserved regions within SARS-CoV-2 proteome.

Identification of Subdominant Cytotoxic T Lymphocyte Epitopes Encoded by Autologous Hiv Type 1 Sequences, Using Dendritic Cell Stimulation and Computer-Driven Algorithm

Repeated Epitope In The Recombinant Epitope-Peptide Could Enhance Eldkwa-Epitope-Specific Antibody Response

Effective assessment of CD4 T cell Immunodominance patterns: impact of antigen processing and HLA restriction

Influence of antigen dose and DC number on CD8+ T cell differentiation and proliferation of OT-Ⅰ transgenic mice

PRR adjuvants restrain high stability peptides presentation on APCs